ETF Opportunities Trust Tuttle Capital Shareholders First Index ETF (BATS: ESGX)

Dernières nouvelles pour ETF Opportunities Trust Tuttle Capital Shareholders First Index ETF (BATS:ESGX)

Tuttle Capital Shareholders First Index ETF

ETF Opportunities Trust Tuttle Capital Shareholders First Index ETF

WIIM

ENSC

Ensysce Biosciences shares are trading higher after the company announced treatment for its first group of subjects in the PF614-MPAR-102 study.

News

Analyst Ratings

Trading Ideas

Live On CNBC, Stephanie Link Announces Bought Accenture

TD Cowen analyst Steven Mah reiterates Twist Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) with a Buy and maintains $58 price target.

Price Target

Reiteration

TWST

TD Cowen Reiterates Buy on Twist Bioscience, Maintains $58 Price Target

Amazon solidified its position as the go-to destination for holiday shoppers this year, with consumer spending trends signaling a robust holiday <a href="https://www.benzinga.com/news/econ-s">season despite economic uncertainties. </a>
According to Goldman Sachs&#8217; 2024 Holiday Survey, authored a team of analysts led by Brooke Roach, CFA, 35% of U.S. consumers indicated Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) as their top choice for holiday spending, marking a notable year-over-year (Y/Y) increase, and outpacing other retail giants like Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), Target Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>), and Costco Wholesale Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>).
<h1 class="wp-block-heading">Amazon, Walmart Lead, But The Gap Widens</h1>
Amazon and Walmart continue to be the two most preferred retailers during the holiday season.
Walmart, while holding its ground as the second most popular choice, experienced a slight decline in preference, along with Best Buy. Meanwhile, Target and Costco trailed behind but posted modest gains in their share of consumer spending intent.
The shift reflects Amazon&#8217;s growing dominance in online retail, bolstered by early promotional events such as its July and October Prime Days.
These events appear to have captured consumer attention early, with over half of shoppers starting their holiday shopping before Thanksgiving — a trend consistent with previous years.
<h1 class="wp-block-heading">Online Shopping Remains King</h1>
E-commerce remains the reigning channel for holiday purchases, with more consumers opting to shop online this year compared to 2023. 
"Online shopping remains the preferred shopping channel," the report stated. 
The survey revealed that 45% of male consumers and 38% of female consumers plan to do the majority of their shopping digitally — a two percentage point increase Y/Y for both groups.
Younger demographics are driving this trend: Over 50% of Gen Z and Millennial shoppers said they plan to complete the bulk of their holiday shopping online, favoring the convenience of digital platforms. 
"Electronics saw the largest increase in consumer preference for online shopping compared to last year (+4pts Y/Y), followed by gift cards, media and experiential gifts (all +3pts Y/Y)," Goldman Sachs wrote. 
<h1 class="wp-block-heading">Black Friday Is Back in Style</h1>
While early shopping trends are on the rise, Black Friday continues to hold its ground as a pivotal moment in the holiday shopping season. The survey showed a two-point increase in the number of consumers planning to complete their holiday shopping on or before Black Friday compared to last year and an 11-point jump compared to 2019.
This year, the calendar provides an added boost: Black Friday falls five days later than in 2023, giving shoppers additional time to prepare. 
Notably, low-income consumers remain the most likely to take advantage of Black Friday deals, emphasizing the importance of sales and promotions in driving their spending decisions.
Read Now:
<ul>
<li><a href="https://www.benzinga.com/etfs/currency-etfs/24/11/42190765/trumps-tariff-threats-slam-mexican-peso-canadian-dollar-only-the-beginning-of-a-sorely-needed-repricing-expert-warns">Mexican Peso, Canadian Dollar Slide As Ackman Says Trump Will Use Tariffs &#8216;As A Weapon&#8217;</a></li>
</ul>
Photo: Shutterstock

Psychology

AMZN

COST

Amazon Dominates Holiday Shopping As Black Friday Spending Soars: Goldman Sachs

TD Cowen analyst Jason Gabelman maintains Cheniere Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>) with a Buy and raises the price target from $202 to $242.

TD Cowen Maintains Buy on Cheniere Energy, Raises Price Target to $242

UCloudlink Group shares are trading lower after the company reported worse-than-expected Q3 sales results.

Office Properties Income Trust shares are trading higher. The company announced a debt refinancing plan for up to $340 million in senior unsecured notes

B. Riley Securities analyst Naved Khan maintains ACV Auctions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACVA#NASDAQ">ACVA</a>) with a Buy and raises the price target from $24 to $27.

ACVA

B. Riley Securities Maintains Buy on ACV Auctions, Raises Price Target to $27

Raymond James analyst Savanthi Syth reiterates Vertical Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTL#NYSE">EVTL</a>) with a Market Perform.

EVTL

Raymond James Reiterates Market Perform on Vertical Aerospace

B. Riley Securities analyst Hal Goetsch maintains Shift4 Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) with a Buy and raises the price target from $110 to $150.

FOUR

B. Riley Securities Maintains Buy on Shift4 Payments, Raises Price Target to $150

B. Riley Securities analyst Craig Kennison maintains Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) with a Buy and raises the price target from $61 to $85.

SMTC

B. Riley Securities Maintains Buy on Semtech, Raises Price Target to $85

Real Good Food Company shares are trading higher. The company requested an extension regarding its Nasdaq delinquency notice.

<h3>The partnership will connect advertisers in a privacy-protective manner to SMB audiences to create more accurate and better-performing B2B marketing campaigns</h3>
REDWOOD CITY, Calif – November 26, 2024&nbsp;– PubMatic, an independent technology company delivering digital advertising's supply chain of the future, announced a new strategic partnership with Intuit's SMB MediaLabs that will make rich first-party SMB audiences available in PubMatic's self-service Convert platform for commerce media. This collaboration will enable publishers and advertisers to access unparalleled data-led targeting capabilities, significantly enhancing B2B marketing campaign performance and accuracy.
Intuit's SMB MediaLabs is a first-of-its-kind media network focused solely on small and medium-sized businesses. It reaches an audience of millions of small and medium businesses leveraging 36 million identifiers through Intuit QuickBooks, while keeping the underlying customer data secure on Intuit's platform. SMB MediaLabs launched in July 2023 as a managed service via insertion orders. Now, in partnership with PubMatic, enterprise-level and large holding company buyers and publishers offering premium, brand-safe inventory across CTV, video, mobile and more will be able to connect marketers to this attractive audience-segment through PubMatic. Plus, SMB MediaLabs advertisers will be able to connect to these data segments directly via PubMatic's self-service Convert platform, a flexible, integrated white-label tech solution for retailers and marketplaces.

INTU

PUBM

Pubmatic Forges Partnership With Intuit SMB Medialabs To Advance B2B Advertising With Privacy-Protective Solutions

B. Riley Securities analyst Eric Wold downgrades Brunswick (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BC#NYSE">BC</a>) from Buy to Neutral and lowers the price target from $95 to $88.

Downgrades

B. Riley Securities Downgrades Brunswick to Neutral, Lowers Price Target to $88

VEEA

Veea shares are trading higher after the company announced partnership  based on MARQUEE's patented SMARTCELL platform. Under the initiative, Veea's decentralized physical infrastructure network will accelerate the introduction of MEC solutions with Edge AI as an extension of the cellular network inftrascuture.

On Monday, the Centers for Medicare &amp; Medicaid Services posted final payment determinations for its 2025 Clinical Laboratory Fee Schedule.
Included was a final decision related to CMS pricing for Exact Sciences Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) Cologuard Plus, a second-generation test that received FDA <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/10/41185292/fda-clears-exact-sciences-next-generation-colorectal-cancer-diagnostic-test" rel="noreferrer noopener">approval in October</a>.
William Blair writes that the <a target="_blank" href="https://www.cms.gov/medicare/payment/fee-schedules/clinical-laboratory-fee-schedule-clfs/annual-public-meetings" rel="noreferrer noopener">determinations</a> effectively raise reimbursement by 16% versus the current Medicare rate for the first-generation Cologuard test (to $592 for Cologuard Plus from $509 for Cologuard).
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41776963/colorectal-cancer-diagnostic-focused-exact-sciences-stock-plunges-on-weak-annual-gu" rel="noreferrer noopener">Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point</a>
The determination reverses the September preliminary decision but aligns with a proposal made during the public comment period.
The analyst writes that reimbursement for Cologuard Plus will now be calculated based on two components: three times the fee for methylation analysis of Septin-9 ($192 x 3) and the fee for a FIT test ($15.92).
This pricing adjustment is expected to take effect for Medicare volumes when the test officially launches in late first quarter or early second quarter of 2025. Medicare fee-for-service volumes should reflect the new pricing immediately upon launch, with Medicare Advantage following soon after.
The company is also likely to renegotiate commercial contracts for higher pricing, which may gradually roll out over the coming quarters and years.
William Blair reiterates the <a target="_blank" href="https://www.benzinga.com/quote/EXAS/analyst-ratings" rel="noreferrer noopener">Outperform rating on the stock.</a>
The analyst highlights that the update is a positive outcome for the company, as it simplifies the process of implementing a price increase compared to the more complex advanced diagnostic laboratory test (ADLT) pathway.
From a financial perspective, this decision is expected to support a moderate pricing boost starting in 2025. Based on William Blair&#8217;s estimates, this could add at least 300 basis points to Cologuard's growth rate next year, which is projected to be around 15% overall.
Exact Sciences said it will present 10 abstracts demonstrating the breadth of its Precision Oncology portfolio at the 2024 annual San Antonio Breast Cancer Symposium <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42177702/exact-sciences-advances-breast-cancer-care-with-the-oncotype-dx-test-and-genomic-profiling-researc" rel="noreferrer noopener">scheduled next month</a>.
Price Action: EXAS stock is up 7.60% at $59.33 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42190381/analog-devices-q4-earnings-beats-estimates-automotive-rebound-outlook" target="_blank" rel="noreferrer noopener">Analog Devices Q4 Earnings: Beats Estimates, Automotive Rebound, Cautiously Optimistic Outlook &amp; More</a></li>
</ul>
Illustration of Phrama lab worker created with MidJourney.

Analyst Color

Equities

Health Care

Movers

General

EXAS

Why Is Exact Sciences Stock Trading Higher On Monday?

CIMG Shares Resume Trade

Truist Securities analyst Keith Hughes downgrades Summit Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUM#NYSE">SUM</a>) from Buy to Hold and lowers the price target from $60 to $52.5.

Truist Securities Downgrades Summit Materials to Hold, Lowers Price Target to $52.5

TD Cowen analyst Ryan Langston maintains Universal Health Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) with a Buy and lowers the price target from $275 to $251.

Comments

ETF Opportunities Trust Tuttle Capital Shareholders First Index ETF

Actualités

Dernières nouvelles pour ETF Opportunities Trust Tuttle Capital Shareholders First Index ETF (BATS:ESGX)

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL